US Stock MarketDetailed Quotes

SOPH Sophia Genetics

Watchlist
  • 3.130
  • -0.040-1.26%
Close Nov 21 16:00 ET
207.95MMarket Cap-2871P/E (TTM)

Sophia Genetics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
31.13%-8.38M
3.14%-10M
6.42%-13.84M
30.70%-48.58M
-9.32%-11.29M
46.67%-12.17M
47.18%-10.32M
15.00%-14.79M
-20.98%-70.09M
33.01%-10.33M
Net income from continuing operations
-35.35%-18.31M
29.50%-15.03M
31.67%-13.39M
10.38%-78.5M
-69.04%-24.05M
42.23%-13.53M
13.63%-21.32M
22.42%-19.59M
-19.15%-87.59M
35.02%-14.23M
Operating gains losses
---182K
----
----
--28K
--0
----
----
----
----
----
Depreciation and amortization
0.55%2.21M
-10.03%2.04M
8.94%2.06M
49.63%8.34M
27.72%1.98M
52.32%2.2M
63.23%2.26M
59.09%1.89M
54.36%5.57M
26.20%1.55M
Deferred tax
4.32%-177K
-20.13%-179K
76.94%-104K
12.62%-1.13M
-156.72%-344K
56.57%-185K
54.43%-149K
-11.36%-451K
19.10%-1.29M
88.68%-134K
Other non cash items
806.83%3.41M
-157.22%-701K
-3,085.80%-5.05M
421.31%2.2M
298.46%1.29M
-90.16%-483K
2,211.32%1.23M
1.81%169K
-429.33%-685K
60.51%-650K
Change In working capital
125.99%1.4M
-140.47%-1.08M
-55.60%-1.7M
168.50%872K
38,775.00%4.67M
-27.25%-5.38M
754.28%2.68M
-132.53%-1.09M
-120.80%-1.27M
-99.80%12K
-Change in receivables
137.68%771K
-62.57%874K
168.41%2.17M
-587.99%-6.5M
-278.77%-3.62M
-2,187.76%-2.05M
395.94%2.34M
-158,350.00%-3.17M
-26.25%1.33M
-31.91%2.03M
-Change in inventory
1,271.67%703K
9.88%-1.03M
-57.08%376K
-337.00%-874K
-254.24%-546K
77.78%-60K
-26.97%-1.14M
41.98%876K
91.44%-200K
135.05%354K
-Change in prepaid assets
25.11%-1.35M
652.48%1.12M
78.81%-182K
240.74%1.38M
17,583.33%4.24M
-22.58%-1.81M
-65.57%-202K
-244.13%-859K
58.07%-977K
-99.25%24K
-Change in payables and accrued expense
187.24%1.28M
-221.04%-2.04M
-296.80%-4.06M
581.16%6.87M
291.84%4.59M
43.22%-1.47M
20.24%1.69M
-3.64%2.06M
-115.90%-1.43M
-375.14%-2.39M
Cash from discontinued investing activities
Operating cash flow
31.13%-8.38M
3.14%-10M
6.42%-13.84M
30.70%-48.58M
-9.32%-11.29M
46.67%-12.17M
47.18%-10.32M
15.00%-14.79M
-20.98%-70.09M
33.01%-10.33M
Investing cash flow
Cash flow from continuing investing activities
-10.47%-2.32M
-7.76%-1.96M
-113.52%-1.96M
-80.18%8.32M
-118.53%-2.25M
-167.08%-2.1M
-110.10%-1.82M
66.24%14.49M
173.72%41.97M
1,043.12%12.14M
Capital expenditure reported
-27.93%-2.22M
4.14%-1.83M
-93.48%-1.81M
-28.33%-7.47M
-26.65%-2.89M
-127.73%-1.73M
-22.17%-1.91M
22.92%-935K
-50.86%-5.82M
-72.06%-2.29M
Net PPE purchase and sale
38.21%-76K
98.37%-12K
80.51%-99K
63.53%-1.49M
93.49%-125K
86.48%-123K
-4.68%-738K
9.45%-508K
-52.70%-4.1M
-1,172.19%-1.92M
Net intangibles purchase and sale
88.57%-28K
76.79%-117K
82.39%-50K
43.32%-263K
-25.46%770K
49.80%-245K
25.33%-504K
14.97%-284K
-256.92%-464K
51,550.00%1.03M
Net investment purchase and sale
--0
--0
--0
-66.49%17.55M
--0
--0
-93.63%1.33M
49.82%16.21M
204.16%52.35M
7,958.42%15.31M
Cash from discontinued investing activities
Investing cash flow
-10.47%-2.32M
-7.76%-1.96M
-113.52%-1.96M
-80.18%8.32M
-118.53%-2.25M
-167.08%-2.1M
-110.10%-1.82M
66.24%14.49M
173.72%41.97M
1,043.12%12.14M
Financing cash flow
Cash flow from continuing financing activities
21.66%-593K
2,256.22%13.35M
36.26%-596K
-79.66%-2.82M
12.76%-506K
6.43%-757K
-366.81%-619K
-127.49%-935K
-100.66%-1.57M
-29.75%-580K
Net issuance payments of debt
12.15%-665K
2,053.78%13.19M
32.32%-735K
-31.39%-3.04M
9.48%-525K
5.14%-757K
-44.23%-675K
-131.06%-1.09M
43.30%-2.32M
-185.71%-580K
Net common stock issuance
----
----
----
--0
----
----
----
----
--0
----
Proceeds from stock option exercised by employees
--72K
96.43%110K
24.50%188K
-69.79%226K
--19K
--0
-92.00%56K
155.93%151K
-83.48%748K
--0
Net other financing activities
----
----
---49K
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
21.66%-593K
2,256.22%13.35M
36.26%-596K
-79.66%-2.82M
12.76%-506K
6.43%-757K
-366.81%-619K
-127.49%-935K
-100.66%-1.57M
-29.75%-580K
Net cash flow
Beginning cash position
-29.05%105.4M
-35.47%103.74M
-23.59%123.25M
-16.41%161.31M
-15.88%132.77M
-16.96%148.55M
-12.11%160.76M
-16.41%161.31M
158.58%192.96M
-24.84%157.83M
Current changes in cash
24.83%-11.3M
110.89%1.39M
-1,224.15%-16.39M
-45.08%-43.07M
-1,242.96%-14.05M
26.68%-15.03M
-862.94%-12.76M
86.39%-1.24M
-124.16%-29.69M
107.16%1.23M
Effect of exchange rate changes
322.85%1.69M
-50.64%271K
-549.35%-3.12M
354.85%5.02M
101.47%4.53M
-30.97%-757K
120.43%549K
172.93%695K
56.85%-1.97M
1,699.20%2.25M
End cash Position
-27.85%95.79M
-29.05%105.4M
-35.47%103.74M
-23.59%123.25M
-23.59%123.25M
-15.88%132.77M
-16.96%148.55M
-12.11%160.76M
-16.41%161.31M
-16.41%161.31M
Free cash flow
25.00%-10.7M
11.25%-11.96M
4.35%-15.8M
28.17%-57.8M
-0.29%-13.54M
42.87%-14.27M
40.09%-13.47M
15.33%-16.52M
-24.55%-80.47M
20.09%-13.5M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 31.13%-8.38M3.14%-10M6.42%-13.84M30.70%-48.58M-9.32%-11.29M46.67%-12.17M47.18%-10.32M15.00%-14.79M-20.98%-70.09M33.01%-10.33M
Net income from continuing operations -35.35%-18.31M29.50%-15.03M31.67%-13.39M10.38%-78.5M-69.04%-24.05M42.23%-13.53M13.63%-21.32M22.42%-19.59M-19.15%-87.59M35.02%-14.23M
Operating gains losses ---182K----------28K--0--------------------
Depreciation and amortization 0.55%2.21M-10.03%2.04M8.94%2.06M49.63%8.34M27.72%1.98M52.32%2.2M63.23%2.26M59.09%1.89M54.36%5.57M26.20%1.55M
Deferred tax 4.32%-177K-20.13%-179K76.94%-104K12.62%-1.13M-156.72%-344K56.57%-185K54.43%-149K-11.36%-451K19.10%-1.29M88.68%-134K
Other non cash items 806.83%3.41M-157.22%-701K-3,085.80%-5.05M421.31%2.2M298.46%1.29M-90.16%-483K2,211.32%1.23M1.81%169K-429.33%-685K60.51%-650K
Change In working capital 125.99%1.4M-140.47%-1.08M-55.60%-1.7M168.50%872K38,775.00%4.67M-27.25%-5.38M754.28%2.68M-132.53%-1.09M-120.80%-1.27M-99.80%12K
-Change in receivables 137.68%771K-62.57%874K168.41%2.17M-587.99%-6.5M-278.77%-3.62M-2,187.76%-2.05M395.94%2.34M-158,350.00%-3.17M-26.25%1.33M-31.91%2.03M
-Change in inventory 1,271.67%703K9.88%-1.03M-57.08%376K-337.00%-874K-254.24%-546K77.78%-60K-26.97%-1.14M41.98%876K91.44%-200K135.05%354K
-Change in prepaid assets 25.11%-1.35M652.48%1.12M78.81%-182K240.74%1.38M17,583.33%4.24M-22.58%-1.81M-65.57%-202K-244.13%-859K58.07%-977K-99.25%24K
-Change in payables and accrued expense 187.24%1.28M-221.04%-2.04M-296.80%-4.06M581.16%6.87M291.84%4.59M43.22%-1.47M20.24%1.69M-3.64%2.06M-115.90%-1.43M-375.14%-2.39M
Cash from discontinued investing activities
Operating cash flow 31.13%-8.38M3.14%-10M6.42%-13.84M30.70%-48.58M-9.32%-11.29M46.67%-12.17M47.18%-10.32M15.00%-14.79M-20.98%-70.09M33.01%-10.33M
Investing cash flow
Cash flow from continuing investing activities -10.47%-2.32M-7.76%-1.96M-113.52%-1.96M-80.18%8.32M-118.53%-2.25M-167.08%-2.1M-110.10%-1.82M66.24%14.49M173.72%41.97M1,043.12%12.14M
Capital expenditure reported -27.93%-2.22M4.14%-1.83M-93.48%-1.81M-28.33%-7.47M-26.65%-2.89M-127.73%-1.73M-22.17%-1.91M22.92%-935K-50.86%-5.82M-72.06%-2.29M
Net PPE purchase and sale 38.21%-76K98.37%-12K80.51%-99K63.53%-1.49M93.49%-125K86.48%-123K-4.68%-738K9.45%-508K-52.70%-4.1M-1,172.19%-1.92M
Net intangibles purchase and sale 88.57%-28K76.79%-117K82.39%-50K43.32%-263K-25.46%770K49.80%-245K25.33%-504K14.97%-284K-256.92%-464K51,550.00%1.03M
Net investment purchase and sale --0--0--0-66.49%17.55M--0--0-93.63%1.33M49.82%16.21M204.16%52.35M7,958.42%15.31M
Cash from discontinued investing activities
Investing cash flow -10.47%-2.32M-7.76%-1.96M-113.52%-1.96M-80.18%8.32M-118.53%-2.25M-167.08%-2.1M-110.10%-1.82M66.24%14.49M173.72%41.97M1,043.12%12.14M
Financing cash flow
Cash flow from continuing financing activities 21.66%-593K2,256.22%13.35M36.26%-596K-79.66%-2.82M12.76%-506K6.43%-757K-366.81%-619K-127.49%-935K-100.66%-1.57M-29.75%-580K
Net issuance payments of debt 12.15%-665K2,053.78%13.19M32.32%-735K-31.39%-3.04M9.48%-525K5.14%-757K-44.23%-675K-131.06%-1.09M43.30%-2.32M-185.71%-580K
Net common stock issuance --------------0------------------0----
Proceeds from stock option exercised by employees --72K96.43%110K24.50%188K-69.79%226K--19K--0-92.00%56K155.93%151K-83.48%748K--0
Net other financing activities -----------49K----------------------------
Cash from discontinued financing activities
Financing cash flow 21.66%-593K2,256.22%13.35M36.26%-596K-79.66%-2.82M12.76%-506K6.43%-757K-366.81%-619K-127.49%-935K-100.66%-1.57M-29.75%-580K
Net cash flow
Beginning cash position -29.05%105.4M-35.47%103.74M-23.59%123.25M-16.41%161.31M-15.88%132.77M-16.96%148.55M-12.11%160.76M-16.41%161.31M158.58%192.96M-24.84%157.83M
Current changes in cash 24.83%-11.3M110.89%1.39M-1,224.15%-16.39M-45.08%-43.07M-1,242.96%-14.05M26.68%-15.03M-862.94%-12.76M86.39%-1.24M-124.16%-29.69M107.16%1.23M
Effect of exchange rate changes 322.85%1.69M-50.64%271K-549.35%-3.12M354.85%5.02M101.47%4.53M-30.97%-757K120.43%549K172.93%695K56.85%-1.97M1,699.20%2.25M
End cash Position -27.85%95.79M-29.05%105.4M-35.47%103.74M-23.59%123.25M-23.59%123.25M-15.88%132.77M-16.96%148.55M-12.11%160.76M-16.41%161.31M-16.41%161.31M
Free cash flow 25.00%-10.7M11.25%-11.96M4.35%-15.8M28.17%-57.8M-0.29%-13.54M42.87%-14.27M40.09%-13.47M15.33%-16.52M-24.55%-80.47M20.09%-13.5M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data